↓ Skip to main content

Dove Medical Press

Challenges faced in managing dementia in Alzheimer’s disease in patients with Down syndrome

Overview of attention for article published in Degenerative Neurological and Neuromuscular Disease, September 2016
Altmetric Badge

Mentioned by

twitter
2 X users

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
48 Mendeley
Title
Challenges faced in managing dementia in Alzheimer’s disease in patients with Down syndrome
Published in
Degenerative Neurological and Neuromuscular Disease, September 2016
DOI 10.2147/dnnd.s91754
Pubmed ID
Authors

Vee P Prasher, Hassan Mahmood, Madhumanti Mitra

Abstract

Dementia in Alzheimer's disease (DAD) is more common in adults with Down syndrome (DS), with characteristically an earlier onset. The treatment of DAD is not too dissimilar in the general population and in people with intellectual disabilities. However, the underlying intellectual disability can make the management of DAD more challenging in older adults with DS. This literature review aimed to look at the management of DAD in people with DS. The management of dementia is holistic. This includes treating reversible factors, aiming to slow the cognitive decline, psychological therapies, ensuring that the environment is appropriate, and use of psychotropic medication when necessary to manage behavioral problems, psychotic symptoms, depressive symptoms, and sleep difficulty. Antidementia medications have a role to play but remain limited. The management of DAD in the DS population can be at times challenging, but good clinical practice should involve accurate diagnosis of dementia, treating any reversible additional factors, consideration of psychological and behavioral management, use of antidementia medication, and a multidisciplinary team approach.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 48 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 48 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 10 21%
Student > Master 8 17%
Student > Doctoral Student 4 8%
Researcher 3 6%
Student > Ph. D. Student 3 6%
Other 6 13%
Unknown 14 29%
Readers by discipline Count As %
Psychology 14 29%
Nursing and Health Professions 6 13%
Medicine and Dentistry 5 10%
Social Sciences 3 6%
Pharmacology, Toxicology and Pharmaceutical Science 2 4%
Other 2 4%
Unknown 16 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 September 2016.
All research outputs
#17,286,645
of 25,374,917 outputs
Outputs from Degenerative Neurological and Neuromuscular Disease
#61
of 96 outputs
Outputs of similar age
#228,248
of 348,371 outputs
Outputs of similar age from Degenerative Neurological and Neuromuscular Disease
#2
of 2 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 96 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.0. This one is in the 29th percentile – i.e., 29% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 348,371 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 26th percentile – i.e., 26% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 2 others from the same source and published within six weeks on either side of this one.